Skip to main content
. 2022 Aug 26;15:6821–6836. doi: 10.2147/IJGM.S376316

Figure 7.

Figure 7

Comparison between the percentage of individuals with and without adverse reactions after their 2nd and 3rd COVID-19 Pfizer-BioNTech vaccine doses according to their age categories. p value derived from Fisher’s exact test.